Phospholipid remodeling and its derivatives are associated with COVID-19 severity-Reference-Cited by-同舟云学术

Phospholipid remodeling and its derivatives are associated with COVID-19 severity

Published:2023-05 Issue:5 Volume:151 Page:1259-1268
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Wei Juntong^ORCID,Liu Xiaoyu,Xiao Weimin,Lu Jiahua,Guan Li,Fang Zhangfu,Chen Jiaping,Sun Baoqing,Cai Zongwei,Sun Xizhuo,Chen Hua-Ling,Zhong Nanshan,Liu Zhigang,Yang Jun,Xiao Xiaojun,Huang Shau-Ku

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19;Thevarajan;Nat Med,2020

2. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention;Wu;JAMA,2020

3. Distinct features of SARS-CoV-2–specific IgA response in COVID-19 patients;Yu;Eur Respir J,2020

4. Metabolic reprogramming of host cells in response to enteroviral infection;Cheng;Cells,2020

5. Energetic and exergetic costs of COVID-19 infection on the body of a patient;Yilmaz;Int J Exergy,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chaiqin chengqi decoction treatment mitigates hypertriglyceridemia-associated acute pancreatitis by modulating liver-mediated glycerophospholipid metabolism;Phytomedicine;2024-11

2. Lipidome is a valuable tool for the severity prediction of coronavirus disease 2019;Frontiers in Immunology;2024-05-10

3. Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy;Protein & Cell;2024-03-05

4. Exploring salivary lipid profile changes in COVID-19 patients: Insights from mass spectrometry analysis;Talanta;2024-03

5. Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis;Clinical and Translational Medicine;2023-11